BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10630892)

  • 21. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.
    Stearns RA; Chakravarty PK; Chen R; Chiu SH
    Drug Metab Dispos; 1995 Feb; 23(2):207-15. PubMed ID: 7736913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
    Ramírez J; Innocenti F; Schuetz EG; Flockhart DA; Relling MV; Santucci R; Ratain MJ
    Drug Metab Dispos; 2004 Sep; 32(9):930-6. PubMed ID: 15319333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NADPH-dependent metabolism of estrone by human liver microsomes.
    Lee AJ; Mills LH; Kosh JW; Conney AH; Zhu BT
    J Pharmacol Exp Ther; 2002 Mar; 300(3):838-49. PubMed ID: 11861789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a non-high pressure liquid chromatography assay to determine testosterone hydroxylase (CYP3A) activity in human liver microsomes.
    Draper AJ; Madan A; Smith K; Parkinson A
    Drug Metab Dispos; 1998 Apr; 26(4):299-304. PubMed ID: 9531515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes.
    Furster C; Wikvall K
    Biochim Biophys Acta; 1999 Jan; 1437(1):46-52. PubMed ID: 9931427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes.
    Hijazi Y; Boulieu R
    Drug Metab Dispos; 2002 Jul; 30(7):853-8. PubMed ID: 12065445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
    Jacobson PA; Green K; Birnbaum A; Remmel RP
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
    Ohmori S; Nakasa H; Asanome K; Kurose Y; Ishii I; Hosokawa M; Kitada M
    Biochim Biophys Acta; 1998 May; 1380(3):297-304. PubMed ID: 9555064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
    Wester MR; Lasker JM; Johnson EF; Raucy JL
    Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective metabolism of ifosfamide by human P-450s 3A4 and 2B6. Favorable metabolic properties of R-enantiomer.
    Roy P; Tretyakov O; Wright J; Waxman DJ
    Drug Metab Dispos; 1999 Nov; 27(11):1309-18. PubMed ID: 10534317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.
    Kiang TK; Ho PC; Anari MR; Tong V; Abbott FS; Chang TK
    Toxicol Sci; 2006 Dec; 94(2):261-71. PubMed ID: 16945988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes.
    Miyazawa M; Gyoubu K
    Xenobiotica; 2007 Feb; 37(2):194-204. PubMed ID: 17484521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties and regional expression of a CYP3A-like protein in channel catfish intestine.
    James MO; Lou Z; Rowland-Faux L; Celander MC
    Aquat Toxicol; 2005 May; 72(4):361-71. PubMed ID: 15848255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21, as well as CYP3A4 in xenobiotic androgen elimination - insights from metandienone metabolism.
    Parr MK; Zöllner A; Fusshöller G; Opfermann G; Schlörer N; Zorio M; Bureik M; Schänzer W
    Toxicol Lett; 2012 Sep; 213(3):381-91. PubMed ID: 22885098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of 3-keto-4-ene steroids and their hydroxylated metabolites catalyzed by recombinant human cytochrome P450 1B1 enzyme using gas chromatography-mass spectrometry with trimethylsilyl derivatization.
    Song J; Wadhwa L; Bejjani BA; O'Brien WE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):127-35. PubMed ID: 12798173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis.
    Wang RW; Newton DJ; Scheri TD; Lu AY
    Drug Metab Dispos; 1997 Apr; 25(4):502-7. PubMed ID: 9107550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5.
    Huang Z; Guengerich FP; Kaminsky LS
    Carcinogenesis; 1998 May; 19(5):867-72. PubMed ID: 9635876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.